Anthera (ANTH) Announces Additional Positive Data Tied to Phase 2b PEARL-SC
Tweet Send to a Friend
Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), announced the final set of clinical data from the Phase 2b PEARL-SC study in patients ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
